LAST NEWS

ARCHIVE ENTRIES

2018.01.14

Advantages of AlloMSCs

Our technology for manufacturing MSC-based medicinal products for veterinary use utilises the therapeutic potential of safe allografts (one donor ... More
2017.05.26

The EMA Scientific Advice procedure

A consultation process through the Scientific Advice procedure has commenced. Our Research and Development Team has prepared questions regarding ... More
2017.03.20

Pracelo enters into a dialogue with the European Medicines Agency

Pracelo has entered into an official dialogue with the European Medicines Agency. On 20 March 2017, an official “pre-submission” meeting took ... More
2017.03.02

Project launched within the 1/1.1.1./2016 “Fast Track” competition

On 02 March 2017, Pracelo signed an agreement on the co-financing for the implementation of the project entitled: “The production of adipose ... More
2017.02.10

Pracelo assigned SME status by the EMA

We are pleased to announce that our application for the SME status had been approved by the European Medicines Agency, which means that Pracelo ... More
2016.11.10

Pracelo recommended for the “Fast Track”

We are pleased to announce that Pracelo has been recommended for co-financing within the Smart Growth Operational Programme 2014-2020, ... More
2016.10.14

Pracelo applies for the SME status to the European Medicines Agency

The Company’s Management Board has submitted an application to the European Medicines Agency for assigning SME status to Pracelo Sp. z o.o. ... More